Suppr超能文献

细胞周期蛋白D1 G870A基因多态性与肝细胞癌风险的关联:一项荟萃分析。

Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis.

作者信息

Luo Tao, Chen Jie, Liu Jun-Jie, Li Hang, You Xue-Mei, Wang Hong-Liang, Zhu Shao-Liang, Li Le-Qun

机构信息

Department of Hepatobiliary Surgery.

Department of Ultrasound, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, People's Republic of China.

出版信息

Onco Targets Ther. 2016 Jul 21;9:4483-9. doi: 10.2147/OTT.S108754. eCollection 2016.

Abstract

BACKGROUND

Cyclin D1 (CCND1) G870A polymorphism may be associated with hepatocellular carcinoma (HCC) risk, but the results of previous studies were inconsistent. Available evidence was meta-analyzed to assess their potential association.

METHODS

Databases PubMed, EMBASE, Cochrane Library, Web of Science, Chinese Biomedical Literature database, China National Knowledge Infrastructure, and Google Scholar were systematically searched. Meta-analyses were performed to investigate the association of G870A polymorphism with HCC risk by calculating odds ratios (ORs) and 95% confidence intervals (CIs) from the data of relevant case-control studies.

RESULTS

Results of this meta-analysis of six case-control studies involving 1,030 cases and 1,683 controls indicate that G870A polymorphism was not associated with HCC risk in any of the five genetic models tested (recessive model: AA vs GG + AG: OR =1.38, 95% CI =0.95-2.00, P=0.09; dominant model: AG + AA vs GG: OR =1.38, 95% CI =0.87-2.20, P=0.17; homozygous model: AA vs GG: OR =1.60, 95% CI =0.87-2.94, P=0.13; heterozygous model: AG vs GG: OR =1.24, 95% CI =0.86-1.79, P=0.25; allelic model: A vs G: OR =1.30, 95% CI =0.95-1.80, P=0.10). Subgroup analyses according to ethnicity showing marginally significant association between this single nucleotide polymorphism and HCC risk indicate that G870A may be significantly associated with HCC risk in Caucasian populations (recessive model: AA vs GG + AG: OR =2.34, 95% CI =1.60-3.42, P<0.0001; dominant model: AG + AA vs GG: OR =2.44, 95% CI =1.19-4.97, P=0.01; homozygous model: AA vs GG: OR =3.42, 95% CI =1.80-6.50, P=0.0002; allelic model: A vs G: OR =2.06, 95% CI =1.31-3.24, P=0.002), but not in Asian populations.

CONCLUSION

Available evidence suggests that no significant association between G870A polymorphism and HCC risk was found in either total populations or Asian populations. However, significant association was found in Caucasian populations. These results should be verified and extended in further detailed and well-designed studies involving larger, multiethnic samples.

摘要

背景

细胞周期蛋白D1(CCND1)基因G870A多态性可能与肝细胞癌(HCC)风险相关,但既往研究结果并不一致。对现有证据进行荟萃分析以评估它们之间的潜在关联。

方法

系统检索PubMed、EMBASE、Cochrane图书馆、科学网、中国生物医学文献数据库、中国知网和谷歌学术等数据库。通过计算相关病例对照研究数据的比值比(OR)和95%置信区间(CI),进行荟萃分析以研究G870A多态性与HCC风险的关联。

结果

这项对6项病例对照研究(共1030例病例和1683例对照)的荟萃分析结果表明,在测试的5种遗传模型中,G870A多态性与HCC风险均无关联(隐性模型:AA与GG + AG相比:OR = 1.38,95%CI = 0.95 - 2.00,P = 0.09;显性模型:AG + AA与GG相比:OR = 1.38,95%CI = 0.87 - 2.20,P = 0.17;纯合子模型:AA与GG相比:OR = 1.60,95%CI = 0.87 - 2.94,P = 0.13;杂合子模型:AG与GG相比:OR = 1.24,95%CI = 0.86 - 1.79,P = 0.25;等位基因模型:A与G相比:OR = 1.30,95%CI = 0.95 - 1.80,P = 0.10)。按种族进行的亚组分析显示,该单核苷酸多态性与HCC风险之间存在微弱的显著关联,表明G870A可能与白种人群的HCC风险显著相关(隐性模型:AA与GG + AG相比:OR = 2.34,95%CI = 1.60 - 3.42,P < 0.0001;显性模型:AG + AA与GG相比:OR = 2.44,95%CI = 1.19 - 4.97,P = 0.01;纯合子模型:AA与GG相比:OR = 3.42,95%CI = 1.80 - 6.50,P = 0.0002;等位基因模型:A与G相比:OR = 2.06,95%CI = 1.31 - 3.24,P = 0.002),但在亚洲人群中并非如此。

结论

现有证据表明,在总体人群或亚洲人群中,未发现G870A多态性与HCC风险之间存在显著关联。然而,在白种人群中发现了显著关联。这些结果应在涉及更大规模、多民族样本的进一步详细且设计良好的研究中得到验证和扩展。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验